BPTH Company Profile and Key Details

Q: Who are the executives of BPTH?

Mr. Peter H. Nielsen MBACo-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & TreasurerDr. Thomas A. Walker Ph.D.ConsultantDr. Alan MacKenzie Ph.D.ConsultantMr. Anthony PriceSenior Vice President of Fin., Accounting & Admin.Dr. Ana Tari Ashizawa Ph.D., MBASenior Vice President of Research, Devel. & Clinical DesignDr. Jeffery Lancet M.D.ConsultantMs. Victoria Lake RacRegulatory Consultant

NASDAQ : BPTH

Bio-Path

$0.06

-0.0018-3.03%

At Close 4:00 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Bio-Path Holdings, Inc. (BPTH) stock declined over -0.87%, trading at $0.06 on OTC, down from the previous close of $0.06. The stock opened at $0.06, fluctuating between $0.06 and $0.07 in the recent session.

Stock Snapshot

0.0576

Prev. Close

527.73K

Market Cap

0.0571

Day Low

-0.05

P/E Ratio

-1.14

EPS (TTM)

-18.67

Cash Flow per Share

0.06

Open

9.24M

Number of Shares

0.0689

Day High

95.76%

Free Float in %

0.71

Book Value

3.08K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 19, 2026	0.06	0.06	0.06	0.06	2.19K
Mar 18, 2026	0.06	0.06	0.06	0.06	10.94K
Mar 17, 2026	0.06	0.06	0.06	0.06	36.54K
Mar 16, 2026	0.06	0.06	0.06	0.06	20.82K
Mar 13, 2026	0.06	0.07	0.06	0.07	30.02K
Mar 12, 2026	0.06	0.06	0.06	0.06	1.92K
Mar 11, 2026	0.07	0.07	0.07	0.07	3.51K
Mar 10, 2026	0.06	0.07	0.06	0.07	11.83K
Mar 09, 2026	0.06	0.07	0.06	0.06	19.82K
Mar 06, 2026	0.06	0.06	0.06	0.06	6.76K
Mar 03, 2026	0.06	0.06	0.06	0.06	437
Mar 02, 2026	0.07	0.07	0.06	0.07	5.66K
Feb 27, 2026	0.06	0.06	0.06	0.06	33.41K
Feb 26, 2026	0.06	0.06	0.06	0.06	14.79K
Feb 25, 2026	0.07	0.07	0.06	0.06	4.94K
Feb 24, 2026	0.07	0.07	0.06	0.07	28.51K
Feb 23, 2026	0.06	0.07	0.06	0.07	21.08K
Feb 20, 2026	0.07	0.07	0.07	0.07	2.18K
Feb 19, 2026	0.07	0.07	0.07	0.07	51.01K
Feb 18, 2026	0.06	0.07	0.06	0.07	12.6K

Contact Details

Bellaire, TX 77401

United States

https://www.biopathholdings.com 832 742 1357

About Company

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Stock Peers

ODTC

Odonate Therapeutics, Inc.$2,849.50 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 NONOF

Novo Nordisk A/S$144.95 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 NURPF

Neuren Pharmaceuticals Limited$14.00 FNCH

-0.29-2.27%

Finch Therapeutics Group, Inc.$12.50

Frequently Asked Questions

What is the current Bio-Path Holdings, Inc. (BPTH) stock price?

Bio-Path Holdings, Inc. (OTC: BPTH) stock price is $0.06 in the last trading session. During the trading session, BPTH stock reached the peak price of $0.07 while $0.06 was the lowest point it dropped to. The percentage change in BPTH stock occurred in the recent session was -0.87% while the dollar amount for the price change in BPTH stock was - $0.00.

BPTH's industry and sector of operation?

The OTC listed BPTH is part of Biotechnology industry that operates in the broader Healthcare sector. Bio-Path Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BPTH?

Mr. Peter H. Nielsen MBA
Co-Founder, Chairman, Chief Executive Officer, Pres, Chief Financial Officer & Treasurer
Dr. Thomas A. Walker Ph.D.
Consultant
Dr. Alan MacKenzie Ph.D.
Consultant
Mr. Anthony Price
Senior Vice President of Fin., Accounting & Admin.
Dr. Ana Tari Ashizawa Ph.D., MBA
Senior Vice President of Research, Devel. & Clinical Design
Dr. Jeffery Lancet M.D.
Consultant
Ms. Victoria Lake Rac
Regulatory Consultant

How BPTH did perform over past 52-week?

BPTH's closing price is 15.2% higher than its 52-week low of $0.05 where as its distance from 52-week high of $0.23 is -74.96%.

How many employees does BPTH have?

Number of BPTH employees currently stands at 10.

Link for BPTH official website?

Official Website of BPTH is: https://www.biopathholdings.com

How do I contact BPTH?

BPTH could be contacted at phone 832 742 1357 and can also be accessed through its website. BPTH operates from 4710 Bellaire Boulevard, Bellaire, TX 77401, United States.

How many shares of BPTH are traded daily?

BPTH stock volume for the day was 3.08K shares. The average number of BPTH shares traded daily for last 3 months was 17.1K.

What is the market cap of BPTH currently?

The market value of BPTH currently stands at $527.73K with its latest stock price at $0.06 and 9.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	10
Beta	-0.28
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	10
Beta	-0.28
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BPTH Company Profile and Key Details

Bio-Path

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways